JD-5037

CAS No. 1392116-14-1

JD-5037 ( JD 5037;JD5037 )

Catalog No. M11626 CAS No. 1392116-14-1

A selective, peripherally restricted cannabinoid-1(CB1) receptor blocker with IC50 of 1.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 48 In Stock
5MG 78 In Stock
10MG 129 In Stock
25MG 233 In Stock
50MG 350 In Stock
100MG 521 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JD-5037
  • Note
    Research use only, not for human use.
  • Brief Description
    A selective, peripherally restricted cannabinoid-1(CB1) receptor blocker with IC50 of 1.5 nM.
  • Description
    A selective, peripherally restricted cannabinoid-1(CB1) receptor blocker with IC50 of 1.5 nM; shows no effect on CB2 (>10 uM); equieffective with its brain-penetrant parent compound in reducing appetite, body weight, hepatic steatosis, and insulin resistance, even though it does not occupy central CB1R or induce related behaviors.
  • Synonyms
    JD 5037;JD5037
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    CB1R
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1392116-14-1
  • Formula Weight
    572.51
  • Molecular Formula
    C27H27Cl2N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CC(C)[C@@H](C(N)=O)/N=C(N1N=C(C2=CC=C(Cl)C=C2)[C@@H](C3=CC=CC=C3)C1)/NS(=O)(C4=CC=C(Cl)C=C4)=O
  • Chemical Name
    Butanamide, 2-[[[(4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[(4-chlorophenyl)sulfonyl]amino]methylene]amino]-3-methyl-, (2S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chorvat RJ, et al. Bioorg Med Chem Lett. 2012 Oct 1;22(19):6173-80.
2. Tam J, et al. Cell Metab. 2012 Aug 8;16(2):167-79.
3. Knani I, et al. Mol Metab. 2016 Oct 22;5(12):1187-1199.
molnova catalog
related products
  • AM-2232

    AM-2232 is a potent and unselective agonist of the cannabinoid receptors.

  • A-836339

    A-836339 (A836339) is a potent and selective cannabinoid CB2 receptor agonist with Ki of 0.64 and 0.76 nM for human and rat CB2 receptors.

  • EHP-101

    VCE-004.8 is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. VCE-004.8 attenuates adipogenesis and prevents diet-induced obesity.